BCK Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
BCK Partners's AMGN Position: Q3 2026 in Review
BCK Partners held its Amgen (AMGN) position steady in Q3 2026 at 610 shares worth $257K. The position accounts for 0.13% of the portfolio, ranked #25.
BCK Partners first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. The position peaked at $346K in Q3 2024. 1,594 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- BCK Partners held 610 shares of Amgen worth $257K as of Q3 2026.
- BCK Partners left its Amgen share count unchanged in Q3 2026.
- Amgen made up 0.13% of BCK Partners's portfolio in Q3 2026, its #25 holding.
- BCK Partners first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
- BCK Partners's Amgen position peaked at $346K in Q3 2024.
- 1,594 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on BCK Partners's 13F filing for Q3 2026, filed 23 Oct 2026.